|
Ed Addison is a serial entrepreneur, venture management consultant and university professor
engaged in the development and finance of new ventures and technology transfer. Ed focuses on life sciences and
and information technology markets. He has built, financed, and sold multiple ventures. He provides strategic
consulting for technology commercialization through the Infinity Venture Group. Ed's current venture projects include Teraffinity, a computational drug discovery company; Cogent Biomedical, a medical devices company; Euveda Biosciences, a microfluidics cell based assay device company; and Mantevo, a medical search
engine company.
LinkedIn Profile: www.linkedin.com/in/edaddison
|
